Comparison of Everolimus- versus Sirolimus-eluting stents in the provisional Bifurcation stenting guided by intravascular ultrasound: mid-term results of the J-REVERSE registry

详细信息    查看全文

• 作者：Yoshinobu Murasato ; Yoshihisa Kinoshita…
• 关键词：Coronary bifurcation ; Bifurcation stenting ; Everolimus ; eluting stent ; Sirolimus ; eluting stent
• 刊名：Cardiovascular Intervention and Therapeutics
• 出版年：2016
• 出版时间：January 2016
• 年：2016
• 卷：31
• 期：1
• 页码：1-12
• 全文大小：1,630 KB
• 参考文献：1.Tsuchida K, Colombo A, Lefèvre T, Oldroyd KG, Guetta V, Guagliumi G, et al. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II). Eur Heart J. 2007;28:433–42.PubMed CrossRef
  2.Armstrong EJ, Yeo KK, Javed U, Mahmud E, Patel M, Shunk KA, et al. Angiographic stent thrombosis at coronary bifurcations: short- and long-term prognosis. JACC Cardiovasc Interv. 2012;5:57–63.PubMed CrossRef
  3.Steigen TK, Maeng M, Wiseth R, Erglis A, Kumsars I, Narbute I, et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study. Circulation. 2006;114:1955–61.PubMed CrossRef
  4.Hildick-Smith D, de Belder AJ, Cooter N, Curzen NP, Clayton TC, Oldroyd KG, et al. Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies. Circulation. 2010;121:1235–43.PubMed CrossRef
  5.Zimarino M1, Corazzini A, Ricci F, Di Nicola M, De Caterina R. Late thrombosis after double versus single drug-eluting stent in the treatment of coronary bifurcations: a meta-analysis of randomized and observational Studies. JACC. Cardiovasc. Interv. 2013;6:687–95.
  6.Hildick-Smith D, Lassen JF, Albiero R, Lefevre T, Darremont O, Pan M, et al. Consensus from the 5th European Bifurcation Club meeting. EuroIntervention. 2010;6:34–8.PubMed CrossRef
  7.Whitbeck MG, Applegate RJ. Second generation drug-eluting stents: a review of the everolimus-eluting platform. Clin Med Insights Cardiol. 2013;7:115–26.PubMed PubMedCentral
  8.Gada H, Kirtane AJ, Newman W, Sanz M, Hermiller JB, Mahaffey KW, et al. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS Paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions). JACC Cardiovasc Interv. 2013;6:1263–6.PubMed CrossRef
  9.Park KW, Kang SH, Velders MA, Shin DH, Hahn S, Lim WH, et al. Safety and efficacy of everolimus- versus sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trials. Am Heart J. 2013;165:241–50.PubMed CrossRef
  10.Burzotta F, Trani C, Todaro D, Mariani L, Talarico GP, Tommasino A, et al. Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach. JACC Cardiovasc Interv. 2011;4:327–35.PubMed CrossRef
  11.Pan M, Medina A, Suárez de Lezo J, Romero M, Segura J, Martín P, et al. Randomized study comparing everolimus- and sirolimus-eluting stents in patients with bifurcation lesions treated by provisional side
  anch stenting. Catheter Cardiovasc Interv. 2012;80:1165–70.PubMed CrossRef
  12.Park SJ, Kim YH, Park DW, Lee SW, Kim WJ, Suh J, et al. Impact of intravascular ultrasound guidance on long-term death in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv. 2009;2:167–77.PubMed CrossRef
  13.Patel Y, Depta JP, Novak E, Yeung M, Lavine K, Banerjee S, et al. Long-term outcomes with use of intravascular ultrasound for the treatment of coronary bifurcation lesions. Am J Cardiol. 2012;109:960–5.PubMed CrossRef
  14.Chen SL, Ye F, Zhang JJ, Tian NL, Liu ZZ, Santoso T, et al. Intravascular ultrasound-guided systematic two-stent techniques for coronary bifurcation lesions and reduced late stent thrombosis. Catheter Cardiovasc Interv. 2013;81:456–63.PubMed CrossRef
  15.Zhang Y, Farooq V, Garcia-Garcia HM, Bourantas CV, Tian N, Dong S, et al. Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients. EuroIntervention. 2012;8:855–65.PubMed CrossRef
  16.Kanda Y. Investigation of the freely-available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48:452–8.PubMed PubMedCentral CrossRef
  17.Murasato Y. Bench testing of coronary bifurcation stenting technique: how is it done? Does it help technical decision making? In: Moussa ID, Colombo A editors. Tips and tricks in interventional therapy of coronary bifurcation lesions. Informa Healthcare. 2010. pp 193–210.
  18.Murasato Y, Iwasaki K, Yamamoto T, Yagi T, Hikichi Y, Suematsu Y, et al. Optimal kissing balloon inflation after single-stent deployment in a coronary bifurcation model. EuroIntervention. 2014;10:934–41.PubMed CrossRef
  19.Foin N, Sen S, Allegria E, Petraco R, Nijjer S, Francis DP, et al. Maximal expansion capacity with current DES platforms: a critical factor for stent selection in the treatment of left main bifurcations? EuroIntervention. 2013;8:1315–25.PubMed CrossRef
  20.Joner M, Nakazawa G, Finn AV, Quee SC, Coleman L, Acampado E, et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol. 2008;52:333–42.PubMed CrossRef
  21.Sgueglia GA, Burzotta F, Trani C, Todaro D, Talarico GP, Niccoli G, et al. Comparative assessment of mammalian target of rapamycin inhibitor-eluting stents in the treatment of coronary artery bifurcation lesions: the CASTOR-Bifurcation registry. Catheter Cardiovasc Interv. 2011;77:503–9.PubMed CrossRef
  22.Mitsutake Y, Ueno T, Yokoyama S, Sasaki K, Sugi Y, Toyama Y, et al. Coronary endothelial dysfunction distal to stent of first-generation drug-eluting stents. JACC Cardiovasc Interv. 2012;5:966–73.PubMed CrossRef
  23.Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Yamaji K, et al. Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: long-term (5–7 years) follow-up of the coronary revascularization demonstrating outcome Study-Kyoto registry Cohort-2. Circ Cardiovasc Interv. 2014;7:168–79.PubMed CrossRef
  24.Girasis C, Schuurbiers JC, Onuma Y, Aben JP, Weijers B, Morel MA, et al. Advances in two-dimensional quantitative coronary angiographic assessment of bifurcation lesions:improved small lumen diameter detection and automatic reference vessel diameter derivation. EuroIntervention. 2012;7:1326–35.PubMed CrossRef
  25.Waksman R, Legutko J, Singh J, Orlando Q, Marso S, Schloss T, et al. FIRST: fractional flow reserve and intravascular ultrasound relationship study. J Am Coll Cardiol. 2013;61:917–23.PubMed CrossRef
  26.Nallamothu BK, Spertus JA, Lansky AJ, Cohen DJ, Jones PG, Kureshi F, et al. Comparison of clinical interpretation with visual assessment and quantitative coronary angiography in patients undergoing percutaneous coronary intervention in contemporary practice: the assessing angiography (A2) project. Circulation. 2013;127:1793–800.PubMed PubMedCentral CrossRef
  
• 作者单位：Yoshinobu Murasato (1) (12) (2)
  Yoshihisa Kinoshita (3)
  Masahiro Yamawaki (4)
  Toshiro Shinke (5)
  Hiromasa Otake (5)
  Yoshihiro Takeda (6)
  Kenichi Fujii (7)
  Shin-ichiro Yamada (8)
  Yoshihisa Shimada (9)
  Takehiro Yamashita (10)
  Kazuhiko Yumoto (11)
  
  1. Department of Cardiology, Cardiovascular Center, Kyushu Medical Center, 1-8-1, Jigyohama, Fukuoka, Japan
  12. Department of Cardiovascular Medicine, New Yukuhashi Hospital, Yukuhashi, Japan
  2. Clinical Research Institute, Kyushu Medical Center, Fukuoka, Japan
  3. Department of Cardiovascular Medicine, Toyohashi Heart Center, Toyohashi, Japan
  4. Department of Cardiovascular Medicine, Saiseikai Yokohama-Eastern Hospital, Yokohama, Japan
  5. Department of Cardiovascular Medicine, Kobe University, Kobe, Japan
  6. Department of Cardiology, Rinku General Medical Center, Izumi-Sano, Japan
  7. Department of Cardiovascular Medicine, Hyogo Medical University, Nishinomiya, Japan
  8. Department of Cardiovascular Medicine, Himeji Cardiovascular Center, Himeji, Japan
  9. Department of Cardiovascular Medicine, Cardiovascular Center, Shiroyama Hospital, Habikino, Japan
  10. Department of Cardiovascular Medicine, Cardiovascular Center Hokkaido Ono Hospital, Sapporo, Japan
  11. Department of Cardiovascular Medicine, Yokohama Rosai Hospital, Yokohama, Japan
  
• 刊物主题：Cardiology; Interventional Radiology;
• 出版者：Springer Japan
• ISSN：1868-4297

文摘

This study aimed at comparing the mid-term clinical outcome of everolimus-eluting (EES) with sirolimus-eluting (SES) stents in the provisional bifurcation stenting guided by intravascular ultrasound (IVUS). We compared the clinical outcome up to 9-month follow-up results of the prospective J-REVERSE registry of 300 non-left main bifurcation lesions in 298 patients treated with EES (n = 240) and SES (n = 60). The SB dilation with the kissing balloon technique (KBT) was performed in 54 %. The patient and lesion characteristics of the groups were similar. The incidences of SB dissections, occlusions, stenting, and slow flow were similar. A greater luminal volume gain was achieved in the proximal MV after KBT compared in non-KBT treated lesions in the EES group (7.9 ± 2.4 versus 7.0 ± 2.0 mm3/mm, p = 0.002), though not in the SES group. The SB diameter stenosis in the non-KBT treatment at 9 months was greater than the KBT in both groups. The incidence of target lesion revascularisation (TLR) was 5.0 % in the EES versus 8.3 % in the SES group (p = 0.35), and the incidence of major adverse cardiac events, including TLR, myocardial infarction, stent thrombosis, and death was 5.4 % in the EES versus 11.7 % in the SES group (p = 0.15). IVUS-guided provisional stenting with EES achieved a greater luminal gain after than without KBT, and similar clinical outcomes as with SES up to 9-month follow-up. Keywords Coronary bifurcation Bifurcation stenting Everolimus-eluting stent Sirolimus-eluting stent